Press Releases
CiToxLAB Group increases revenue by 25 per cent over full year of 2012
CiToxLAB, a leading CRO in the field of non-clinical research, announces today that the group’s consolidated revenue for 2012 reached EUR 78.4 million...
Press Releases
Global pharmaceutical regulatory affairs specialist ELC Group launches Clinical Trials services
ELC GROUP, one of the fastest-growing providers of regulatory affairs consulting services, today announces the launch of a new Clinical Trials service for...
Press Releases
Ricoh Europe: The Speed of Change is Healthcare’s Biggest Technology-led Headache
New data from a study sponsored by Ricoh1 shows that 92.5 per cent of healthcare, biotech and pharmaceutical executives have become more reliant...
News
New study on Hepatitis C drug treatment in vivo and in vitro
Hepatitis C virus (HCV) infection affects about 4.1 million in the United States and is the primary cause of liver cirrhosis and liver...
Industry Reports
Adocia reports 2012 revenue multiplied by 2.5 with a strong cash position
Adocia , a biotechnology company specialized in the development of ‘best-in-class’ medicines with already approved therapeutic proteins, announces today its revenue for the...
Press Releases
Almac and DSM Collaboration Agreement in Biocatalysis Continues with Success
In October 2012, Almac announced a collaboration agreement with DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM N.V. ,...
News
ViiV Healthcare announces FDA priority review designation for dolutegravir
ViiV Healthcare announced that the U.S. Food and Drug Administration (FDA) has granted a priority review designation to dolutegravir submitted for the treatment...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read